Quantcast
Last updated on April 20, 2014 at 13:20 EDT

Latest Transplantation medicine Stories

2013-07-09 08:27:54

Dr. Michael Har-Noy, founder and CEO of Immunovative Therapies, a biotech company in Israel, discusses a unique approach to cancer treatment, in which its cellular-based drugs stimulate the host immune system to target and kill malignant cells. NEW YORK, July 9, 2013 /PRNewswire-iReach/ -- The most promising way to develop curative treatment that eliminates every cancer cell in a patient, says Dr. Michael Har-Noy, founder and CEO of Immunovative Therapies Ltd., would be by...

2013-07-05 23:00:52

Parker Waichman LLP is concerned that the public has not been properly educated about the clinically proven potential side effects that could result from Medtronic’s Infuse bone graft product. At the same time, the product continues to be used in ways for which it wasn’t approved, which only heightens the risks of side effects for patients undergoing these procedures. New York, New York (PRWEB) July 05, 2013 Parker Waichman LLP, a national law firm dedicated to protecting the rights...

Head Transplants Really Possible
2013-07-02 10:55:18

Brett Smith for redOrbit.com - Your Universe Online Are you sick of being out of shape? Just get a new body. According to a new paper from Italian neurosurgeon Sergio Canavero in the journal Surgical Neurology International, human head transplants are now technically possible. In his paper, Canavero argued spinal cord surgery has advanced to the point where attaching a human head onto a new body Frankenstein-style is actually medically possible. He also outlined the procedure, noting...

2013-06-28 12:22:32

NEW YORK, June 28, 2013 /PRNewswire/ -- As we face a growing gap between those in need and those who give, it is vital to educate readers on the importance of becoming an organ, tissue and bone marrow donor. Mediaplanet's 2013 edition of 'The Future of Transplants' hit newsstands this morning within the weekend edition of USA TODAY. This campaign will continue the constant battle to raise awareness for the need of organ donors by educating readers on the ever-changing world of...

2013-06-27 23:25:38

Mike Peters' Rock and Roll Cancer Foundation, Love Hope Strength, Has Raised $3 Million, Expanded Registries and Harvested 35,000 Blood Stem Cell and Bone Marrow Donors Resulting In 560 Matches in Three Years. This Summer He is Documenting his US Tour with Scottish Band Big Country Hosting Donor Drives, Expeditions, Meeting with Politicians, Supporters, All While Undergoing Chemotherapy Wales, United Kingdom (PRWEB) June 27, 2013 Love Hope Strength Foundation(LHSF), the world's...

2013-06-27 23:16:32

New research report “European Dental Bone Graft Substitutes and Other Biomaterials Market” elaborated by iData Research Inc. has been recently published by Market Publishers Ltd. According to the study, the European market for dental bone graft substitutes, dental membranes and tissue engineering products was estimated at slightly over EUR 198.5 million in 2012. London, UK (PRWEB) June 27, 2013 Low rates of consumer spending on elective surgery negatively impacted a slew of segments...

2013-06-27 12:28:21

- LCP-Tacro(TM), once-daily, demonstrated non-inferiority to Prograf®, twice-daily, based on the composite endpoint of treatment failure at one year (LCP-Tacro(TM) 18.3%, Prograf® 19.6%) HORSHOLM, Denmark, June 27, 2013 /PRNewswire/ -- Veloxis Pharmaceuticals A/S (OMX: VELO) today announced LCP-Tacro(TM) successfully demonstrated non-inferiority compared to tacrolimus (Prograf(®); Astellas Pharma) in its Phase III clinical trial, Study 3002. The Phase III randomized,...

2013-06-26 04:20:57

AMSTERDAM, The Netherlands, June 26, 2013 /PRNewswire/ -- Kiadis Pharma B.V., a clinical stage biopharmaceutical company developing treatments for blood cancers, announced today that it will receive an innovation credit of up to EUR3 million from AgentschapNL, a division of the Dutch Ministry of Economic Affairs, to support the Phase II clinical development of Kiadis Pharma's lead pipeline product, ATIR(TM). Kiadis Pharma is currently conducting a Phase II international...

2013-06-25 12:00:28

A new study by an international team led by Dana-Farber Cancer Institute scientists provides the first statistically-based guidelines for determining whether a stem cell transplant is appropriate for older patients with myelodysplastic syndromes (MDS) – the most common blood disorders in people over 60 years of age, and frequently a precursor for leukemia. Using mathematical models to analyze hundreds of MDS cases from around the world, the researchers found reduced intensity transplants...

2013-06-19 16:25:50

CENTENNIAL, Colo., June 19, 2013 /PRNewswire-USNewswire/ -- AlloSource, one of the nation's largest non-profit providers of skin, bone and soft tissue allografts for use in surgical procedures and the world's largest processor of cellular bone allografts announced today that it has become a Donate Life Partner. Through the new partnership with Donate Life America (DLA), AlloSource is investing in the great work that DLA does to increase the number of lives saved or healed through organ,...


Latest Transplantation medicine Reference Libraries

Bone Marrow Transplantation (journal)
2012-06-04 20:00:41

Bone Marrow Transplantation is a peer-reviewed medical journal published monthly by Nature Publishing Group. As of May 2012, the editor-in-chief is J.M. Goldman (UK). The journal publishes high quality, original research that addresses all aspects of basic biology and clinical use of haemopoietic stem cell transplantation in humans. The broad scope of the journal thus encompasses topics such as stem cell biology, kinetics and cytokine control, transplantation immunology, HLA and matching...

More Articles (1 articles) »